Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: Geneious R7, Maverix Biomics, DNAStar, and more


Biomatters has launched Geneious R7, the latest version of its genomic data analysis software.

This version of the tool includes tools to create and share workflows, perform one-step fragment cloning using Gibson assembly, find rare codons, and new plugins for tree building and viewing, alignment and assembly.

Maverix Biomics is offering reduced pricing for its cloud-based RNA-sequencing analysis service to federally funded researchers that will last for the duration of the government shutdown.

The company is charging $99 per sample for RNA-seq analysis including data filtering and quality control, differential gene expression quantification, and visualization capabilities. It will take orders with a minimum of 10 samples and up to 50 million reads per sample

DNAStar said this week that it will offer free use of its software for the duration of government shutdown. Interested researchers are encouraged to contact the company for details.

PerkinElmer has launched a new version of its electronic laboratory notebook dubbed E-Notebook 2014. It includes improvements such as full integration with inventory and registration and protocols for numerous biological applications.

PE has also signed an agreement with Tibco Software to offer the Tibco Spotfire data visualization software platform to clinical, translational, and personalized medicine markets.

The developers of the Structural Classification of Proteins, or SCOP, and ASTRAL databases have released version 1.75C of the combined resources.

This release includes bug fixes and automated classification of many new PDB files released before August 29, 2013.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more